Timothy S. Nelson, President and CEO at MAP Pharmaceuticals, Inc. (MAPP), sold 80,000 shares at $24.76 ($2.0M) on 2013-01-23, disclosed to the SEC on 2013-01-25.
Scheduled sale ($2.0M) by President and CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| MAPP | SELL | 2010-07-02 | $182K | — | Filing → |
| MAPP | SELL | 2010-06-03 | $432K | — | Filing → |
| MAPP | SELL | 2010-05-14 | $513K | — | Filing → |